Fresenius | FRE - Current Liabilities

Stock Price
46.82
Daily Change
0.21 0.45%
Monthly
-8.41%
Yearly
17.28%
Q1 Forecast
45.46

Fresenius reported EUR9.56B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.21B 631M Dec/2025
Alcon AG USD 3.05B 59M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
BASF EUR 16.41B 838M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Beiersdorf EUR 3.51B 261M Dec/2025
DaVita Healthcare Partners USD 3.14B 124.51M Dec/2025
Demant DKK 7.42B 1.63B Dec/2025
E.ON EUR 28.08B 2.45B Dec/2025
Essilor EUR 12.15B 766M Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 6.25B 485.68M Dec/2025
Getinge SEK 15.05B 169M Dec/2024
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GN Store Nord DKK 7.32B 153M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 9.04B 405M Dec/2025
Novartis USD 32B 286M Sep/2025
Philips EUR 7.51B 479M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
RWE EUR 20.3B 3.14B Sep/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025